Janiczek Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$269K Sell
3,924
-1,593
-29% -$106K 0.06% 147
2024
Q1
$404K Sell
5,517
-598
-10% -$46K 0.09% 98
2023
Q4
$495K Buy
6,115
+411
+7% +$32K 0.12% 74
2023
Q3
$427K Buy
5,704
+496
+10% +$38.2K 0.11% 76
2023
Q2
$401K Buy
5,208
+525
+11% +$41.9K 0.11% 65
2023
Q1
$389K Buy
4,683
+109
+2% +$9.03K 0.11% 66
2022
Q4
$392K Sell
4,574
-65
-1% -$5.15K 0.11% 66
2022
Q3
$299K Buy
4,639
+2,335
+101% +$147K 0.1% 68
2022
Q2
$138K Sell
2,304
-378
-14% -$23.4K 0.04% 152
2022
Q1
$159K Buy
2,682
+1,910
+247% +$122K 0.04% 147
2021
Q4
$56K Buy
772
+15
+2% +$1.03K 0.02% 290
2021
Q3
$53K Buy
757
+173
+30% +$12.2K 0.02% 270
2021
Q2
$40K Buy
584
+26
+5% +$1.74K 0.01% 294
2021
Q1
$36K Buy
558
+317
+132% +$20.4K 0.01% 291
2020
Q4
$14K Buy
241
+176
+271% +$10.6K 0.01% 406
2020
Q3
$4K Buy
+65
New +$4.51K ﹤0.01% 380

Other funds holding GILD

Janiczek Wealth Management's GILD Position: Q2 2024 in Review

Janiczek Wealth Management reduced its Gilead Sciences (GILD) stake by 29% in Q2 2024, selling an estimated $106K and leaving 3,924 shares worth $269K. The position accounts for 0.06% of the portfolio, ranked #147.

Janiczek Wealth Management first reported a position in GILD in Q3 2020 and has held it in 16 quarters since. The position peaked at $495K in Q4 2023. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Janiczek Wealth Management held 3,924 shares of Gilead Sciences worth $269K as of Q2 2024.
  • Janiczek Wealth Management sold 1,593 Gilead Sciences shares in Q2 2024, an estimated $106K.
  • Gilead Sciences made up 0.06% of Janiczek Wealth Management's portfolio in Q2 2024, its #147 holding.
  • Janiczek Wealth Management first reported a position in Gilead Sciences in Q3 2020 and has held it in 16 quarters since.
  • Janiczek Wealth Management's Gilead Sciences position peaked at $495K in Q4 2023.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.